{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T15:20:16Z","timestamp":1720279216552},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/fjc.0b013e3181bfadfd","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T15:29:22Z","timestamp":1261063762000},"page":"520-525","source":"Crossref","is-referenced-by-count":11,"title":["Angiotensin Type 1 Receptor Expression and Interleukin-8 Production in Polymorphonuclear Leukocytes of Patients With Peripheral Arterial Disease"],"prefix":"10.1097","volume":"54","author":[{"given":"Franca","family":"Marino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigina","family":"Guasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Tozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramona","family":"Consuelo Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luana","family":"Castiglioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Rasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Legnaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Piffaretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizio","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille","family":"Venco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Lecchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210208","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0033-0620(98)80008-X","article-title":"Cholesterol, cholesterol lowering, and endothelium function.","volume":"41","author":"Vogel","year":"1998","journal-title":"Progr Cardiovasc Dis"},{"key":"R2-9-20210208","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis: an inflammatory disease.","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-9-20210208","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1161\/01.CIR.94.8.2013","article-title":"Stability and instability: two faces of coronary atherosclerosis.","volume":"94","author":"Davies","year":"1996","journal-title":"Circulation"},{"key":"R4-9-20210208","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Poque J, et al; Evaluation (HOPE) study investigators. Effects of angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.","volume":"342","author":"Yusuf","year":"2000","journal-title":"N Engl J Med"},{"key":"R5-9-20210208","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0735-1097(00)01138-4","article-title":"Irbesartan, an angiotensin II type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis.","volume":"37","author":"Navalkar","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"R6-9-20210208","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000153321.13792.b9","article-title":"Angiotensin II and the endothelium: diverse signals and effects.","volume":"45","author":"Watanabe","year":"2005","journal-title":"Hypertension"},{"key":"R7-9-20210208","first-page":"569","article-title":"Angiotensin II as a pro-inflammatory mediator.","volume":"3","author":"Phillips","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"R8-9-20210208","first-page":"H2701","article-title":"Hypercholesterolemia is associated with enhanced angiotensin AT1-recpeotr expression.","volume":"272","author":"Nickenig","year":"1997","journal-title":"Am J Physiol"},{"key":"R9-9-20210208","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/01.CIR.100.21.2131","article-title":"Statin-sensitive dysregulated AT1 receptor function and density in hypercholesterolemic men.","volume":"100","author":"Nickenig","year":"1999","journal-title":"Circulation"},{"key":"R10-9-20210208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1161\/hc0302.102618","article-title":"The AT1-type angiotensin receptor in oxidative stress and atherogenesis. Part I: oxidative stress and atherogenesis.","volume":"105","author":"Nickenig","year":"2002","journal-title":"Circulation"},{"issue":"Suppl 1","key":"R11-9-20210208","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1097\/01.hjh.0000220402.53869.72","article-title":"Pathophysiological regulation of the AT1-receptor and implications for vascular disease.","volume":"24","author":"Wassmann","year":"2006","journal-title":"J Hypertens"},{"key":"R12-9-20210208","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.atherosclerosis.2007.08.014","article-title":"Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients.","volume":"197","author":"Mazor","year":"2008","journal-title":"Atherosclerosis"},{"key":"R13-9-20210208","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1097\/01.hjh.0000251903.62804.77","article-title":"Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk subjects: a longitudinal study.","volume":"24","author":"Guasti","year":"2006","journal-title":"J Hypertens"},{"key":"R14-9-20210208","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/eurheartj\/ehn138","article-title":"Prolonged statin-induced reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up.","volume":"29","author":"Guasti","year":"2008","journal-title":"Eur Heart J"},{"key":"R15-9-20210208","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/FJC.0b013e31803d35ce","article-title":"Angiotensin II type 1 receptor expression in polymorphonuclear leukocytes from high-risk subjects: changes after treatment with simvastatin.","volume":"49","author":"Marino","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"R16-9-20210208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1523-1755.2003.00744.x","article-title":"Anti-inflammatory and immunomodulatory effects of statins.","volume":"63","author":"Blanco-Colio","year":"2003","journal-title":"Kidney Int"},{"key":"R17-9-20210208","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1124\/mol.59.3.646","article-title":"Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.","volume":"59","author":"Wassmann","year":"2001","journal-title":"Mol Pharmacol"},{"key":"R18-9-20210208","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/HJH.0b013e3282f97dde","article-title":"Simvastatin treatment in subjects at high cardiovascular risk modulates AT1R expression on circulating monocytes and t lymphocytes.","volume":"26","author":"Marino","year":"2008","journal-title":"J Hypertens"},{"key":"R19-9-20210208","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/archinte.163.8.884","article-title":"Critical issues in peripheral arterial disease detection and management: a call to action.","volume":"163","author":"Belch","year":"2003","journal-title":"Arch Intern Med"},{"key":"R20-9-20210208","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.amjopharm.2006.12.006","article-title":"Peripheral arterial disease: a review of disease awareness and management.","volume":"4","author":"Watson","year":"2006","journal-title":"Am J Geriatr Pharmacother"},{"key":"R21-9-20210208","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","article-title":"Medical treatment of peripheral arterial disease and claudication.","volume":"344","author":"Hiatt","year":"2001","journal-title":"N Engl J Med"},{"key":"R22-9-20210208","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jvir.2008.02.006","article-title":"Evaluation and management of patients with peripheral artery disease by interventional radiologists: current practice.","volume":"19","author":"Prince","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"R23-9-20210208","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"R24-9-20210208","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.regpep.2006.01.007","article-title":"Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study.","volume":"134","author":"Rasini","year":"2006","journal-title":"Regul Pept"},{"key":"R25-9-20210208","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.jacc.2004.07.056","article-title":"Intracoronary thermography for detection of high-risk vulnerable plaques.","volume":"44","author":"Madjid","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R26-9-20210208","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.CIR.0000042674.89762.20","article-title":"Neutrophil infiltration of culprit lesions in acute coronary syndromes.","volume":"106","author":"Naruko","year":"2002","journal-title":"Circulation"},{"key":"R27-9-20210208","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1189\/jlb.1106671","article-title":"Involvement of intraplaque hemorrhage in atherothrombosis evolution via neutrophil protease enrichment.","volume":"82","author":"Leclercq","year":"2007","journal-title":"J Leukoc Biol"},{"key":"R28-9-20210208","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1161\/01.ATV.0000131784.50633.4f","article-title":"Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis.","volume":"24","author":"Sugiyama","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R29-9-20210208","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00281-009-0153-8","article-title":"Innate and adaptive immunity in atherosclerosis.","volume":"31","author":"Packard","year":"2009","journal-title":"Semin Immunopathol"},{"key":"R30-9-20210208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1191\/1358863x05vm617oa","article-title":"Inflammatory markers and IL-6 polymorphism in peripheral arterial disease with and without diabetes mellitus.","volume":"10","author":"Danielsson","year":"2005","journal-title":"Vasc Med"},{"key":"R31-9-20210208","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.amjmed.2003.10.029","article-title":"Effects of carvedilol on oxidative stress in polymorphonuclear and mononuclear cells in patients with essential hypertension.","volume":"116","author":"Yasunari","year":"2004","journal-title":"Am J Med"},{"key":"R32-9-20210208","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/00024382-200003000-00004","article-title":"Differential effects of short-term ace and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.","volume":"13","author":"Guba","year":"2000","journal-title":"Shock"},{"key":"R33-9-20210208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1291\/hypres.28.107","article-title":"Benidipine, a long-acting calcium channel blocker, inhibits oxidative stress in polymorphonuclear cells in patients with essential hypertension.","volume":"28","author":"Yasunari","year":"2005","journal-title":"Hypertens Res"},{"key":"R34-9-20210208","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/1358863X07077462","article-title":"Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.","volume":"12","author":"Steinhubl","year":"2007","journal-title":"Vasc Med"},{"key":"R35-9-20210208","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00018-007-7449-4","article-title":"Kawamoto H, et al. Vision Reflections (Minireview) Aspirin: recent developments.","volume":"65","author":"Yasuda","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"R36-9-20210208","doi-asserted-by":"crossref","first-page":"S140","DOI":"10.1301\/nr.2007.dec.S140-S146","article-title":"Inflammatory mechanisms: the molecular basis of inflammation and disease.","volume":"65","author":"Libby","year":"2007","journal-title":"Nutr Rev"},{"key":"R37-9-20210208","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00004872-200404000-00023","article-title":"Prevention of angiotensin II-induced hypertension, cardiovascular hypertrophy and oxidative stress by acetylsalicylic acid in rats.","volume":"22","author":"Wu","year":"2004","journal-title":"J Hypertens"},{"key":"R38-9-20210208","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/jcp.10191","article-title":"Endothelial activation by angiotensin II through NFB and p38 pathways: involvement of NFB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin.","volume":"195","author":"Costanzo","year":"2003","journal-title":"J Cell Physiol"},{"key":"R39-9-20210208","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.ATV.17.2.317","article-title":"Macrophages isolated from human atherosclerotic plaques produce IL-8, and oxysterols may have a regulatory function for IL-8 production.","volume":"17","author":"Liu","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R40-9-20210208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1568010054022114","article-title":"Neutrophil-derived cytokines: potential therapeutic targets in inflammation.","volume":"4","author":"Kasama","year":"2005","journal-title":"Curr Drug Targets Inflamm Allergy"},{"key":"R41-9-20210208","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20040174","article-title":"Role of cytokines in cardiovascular diseases: a focus on endothelial responses to inflammation.","volume":"108","author":"Kofler","year":"2005","journal-title":"Clin Sci"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00005344-200912000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T01:45:32Z","timestamp":1618364732000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005344-200912000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fjc.0b013e3181bfadfd","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}